The data is in for 2019, and we break down the ad dollars being spent in different media and also look at the top brands.
A report from American Marijuana surveyed marijuana users about their pot use during the COVID-19 outbreak.
Despite a pick-up in the pace of approvals the last few years, treatments are available for only 5% of the roughly 7,000 rare diseases.
The Mesothelioma Center surveyed more than 1,000 seniors about seeking care.
Take a look at data points from two recent studies on the media habits of patients and doctors.
Civis Analytics looked at how messages affect parents’ perception of the vaccine.
InCrowd surveyed 240 healthcare professionals, including physicians, nurses, PAs, hospitalists and more.
With the mass shooting epidemic reaching pandemic status, the U.S. should treat this crisis as a public health issue. Doing so with smoking and traffic fatalities led to reduced deaths.
The back-and-forth over the Department of Health and Human Services rule requiring inclusion of list prices in TV drug ads had advertisers scrambling to file Form 2253 submissions to the FDA.
Over the past five years, MM&M has honored 200 individuals as Healthcare Transformers. Here’s how they break down across specialty, geography and gender. Tap the ‘+’ to expand the map.
Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.
OptimizeRx’s Chris DiCostanzo and Rebecca Love explain the value of reaching patients and HCPs when it matters most.
Talking Medicines’ Jo Halliday discussed how the pharmaceutical sector can better understand the voice of the patient.
Learn about Intouch Group’s journey to foster I+D so that its inclusive culture translates into inclusive healthcare marketing.
Any EHR provider delivering a quality solution should be able to answer these six questions.
Please login or register first to view this content.